March 29 (Reuters) - Wall Street securities analysts revised their ratings and price targets
on several U.S.-listed companies, including CytomX Therapeutics, Northern Trust and State Street
on Monday.
HIGHLIGHTS
* CytomX Therapeutics Inc CTMX.O : JP Morgan initiates with overweight rating and PT $14
* Immunocore Holdings Plc IMCR.O : Jefferies initiates with rating buy and target $65
* Northern Trust Corp NTRS.O : Credit Suisse raises target price to $102 from $94
* State Street Corp STT.N : Credit Suisse raises target price to $86 from $81
Following is a summary of research actions on U.S. companies reported by Reuters on Monday.
Stock entries are in alphabetical order.
* CytomX Therapeutics Inc CTMX.O : JP Morgan initiates with overweight rating and PT $14
* Donnelley Financial Solutions Inc DFIN.N : BTIG raises target price to $33 from $30
* Ford Motor Co F.N : Jefferies raises target price to $16 from $14
* General Motors Co GM.N : Jefferies raises target price to $62 from $50
* Immunocore Holdings Plc IMCR.O : Jefferies initiates with rating buy and target $65
* L Brands Inc LB.N : Credit Suisse raises target price to $67 from $64
* Lululemon Athletica Inc LULU.O : Piper Sandler cuts target price to $478 from $490
* Molson Coors Beverage Co TAP.N : Jefferies raises target price to $58 from $53
* Molson Coors Beverage Co TAP.N : JP Morgan raises target price to $46 from $43
* Northern Trust Corp NTRS.O : Credit Suisse raises target price to $102 from $94
* Nuvasive Inc NUVA.O : Piper Sandler raises target price to $75 from $68
* Oxford Industries Inc OXM.N : Citigroup raises price target to $90 from $60
* PVH Corp PVH.N : Piper Sandler raises target price to $109 from $96
* Southwest Gas Holdings Inc SWX.N : JP Morgan raises target price to $69 from $63
* State Street Corp STT.N : Credit Suisse raises target price to $86 from $81
* Surgery Partners Inc SGRY.O : Citigroup raises price target to $55 from $35
(Compiled by Bengaluru Newsroom)
((Diaries@thomsonreuters.com))